Sharps Technology Inc
NASDAQ:STSS
Sharps Technology Inc
Research & Development
Sharps Technology Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Sharps Technology Inc
NASDAQ:STSS
|
Research & Development
-$701.8k
|
CAGR 3-Years
25%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Haemonetics Corp
NYSE:HAE
|
Research & Development
-$62.2m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-3%
|
|
|
ICU Medical Inc
NASDAQ:ICUI
|
Research & Development
-$87.5m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-19%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Research & Development
-$369.9m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-20%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Research & Development
-$177.3m
|
CAGR 3-Years
17%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
-29%
|
|
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Research & Development
-$97.4m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-9%
|
|
Sharps Technology Inc
Glance View
Sharps Technology Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Melville, New York. The company went IPO on 2022-04-14. Sharps Technology, Inc. is a medical device company that has designed and patented various safety syringes and is seeking commercialization by manufacturing and distribution of its products. The firm provides Sharps Provensa, a line of smart safety syringes that offer solutions to global healthcare crises. Its Ultra-Low Waste syringes offer a solution to minimize vaccine waste while offering reliable needlestick protection. Its features include traditional one-handed operation, reliable needlestick protection, passive and automatic safety features activated for maximum protection before withdrawal of the needle from the patient, SharpsLock interchangeable needle heads connect fast from drawing medication to injection, orange color plunger tip contrasts against black color graduation for proper reading of medication, reduces costly discarded medicine from every inefficient injection with its low-dead space syringes, no leakage, and prevents improper reuse of needles and syringes.
See Also
What is Sharps Technology Inc's Research & Development?
Research & Development
-701.8k
USD
Based on the financial report for Dec 31, 2024, Sharps Technology Inc's Research & Development amounts to -701.8k USD.
What is Sharps Technology Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-5%
Over the last year, the Research & Development growth was 33%. The average annual Research & Development growth rates for Sharps Technology Inc have been 25% over the past three years , -5% over the past five years .
